Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Aurelie Millier"'
Autor:
Daria Korchagina, Aurelie Millier, Anne-Lise Vataire, Samuel Aballea, Bruno Falissard, Mondher Toumi
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-11 (2017)
Abstract Background The introduction of the orphan drug legislation led to the increase in the number of available orphan drugs, but the access to them is often limited due to the high price. Social preferences regarding funding orphan drugs as well
Externí odkaz:
https://doaj.org/article/cd8ede17731341ec8e2817fc0add45a8
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84088 (2013)
INTRODUCTION: Triptans have been safely and effectively used in the management of migraine for more than fifteen years, and it seems reasonable to wonder what would be the economic impact of moving a specific triptan to OTC availability. The objectiv
Externí odkaz:
https://doaj.org/article/4676f08f448a4706b18229a53b14f703
Autor:
Kerstin Folkerts, Aurelie Millier, Beata Smela, Elzbieta Olewinska, Niklas Schmedt, Paul Mernagh, Csaba P. Kovesdy
Publikováno v:
Journal of Nephrology. 36:1135-1167
Background Mineralocorticoid receptor antagonists (MRAs) were shown to delay chronic kidney disease (CKD) progression in patients with hypertension and/or heart failure (HF) and proteinuria. Objective We conducted a systematic literature review on re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db241e228ba5030177c26d35c36c48e
https://doi.org/10.1007/s40620-022-01492-w
https://doi.org/10.1007/s40620-022-01492-w
Autor:
Claire Leboucher, Cécile Blein, Valérie Machuron, Kelly Benyounes, Katell Le lay, Aurélie Millier, Romain Supiot, François Raffi
Publikováno v:
Journal of Market Access & Health Policy, Vol 11, Iss 1 (2023)
ABSTRACTBackground The economic consequences of the recent COVID-19 pandemic were substantial. However, direct medical costs in France have not been determined.Objective To describe patient characteristics, intensity of care, mortality, and direct me
Externí odkaz:
https://doaj.org/article/15497970cafa464081617ec53bd8ae24
Publikováno v:
Clinical therapeutics. 37(9)
Purpose UR-1505 is a new small molecule with immune modulator properties intended for the topical treatment of inflammatory skin diseases that has shown anti-inflammatory effects in models of skin inflammation. We compared the activity of UR-1505 oin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d510f0b546bde08c912920ffd79f37c6
https://pubmed.ncbi.nlm.nih.gov/26163200
https://pubmed.ncbi.nlm.nih.gov/26163200
Autor:
Aurélie Millier, Romain Supiot, Kelly Benyounes, Valérie Machuron, Katell Le Lay, Marine Sivignon, Claire Leboucher, Cécile Blein, François Raffi
Publikováno v:
Journal of Market Access & Health Policy, Vol 10, Iss 1 (2022)
Background Quantification of COVID-19 burden may be useful to support the future allocation of resources.Objective To evaluate the public health impact of COVID-19 in French ambulatory patients with at least one risk factor for severe disease.Study d
Externí odkaz:
https://doaj.org/article/127e431a65e14202bacc9742e0797ce4
Autor:
Carlos Escobar Cervantes, Julio Martí-Almor, Alejandro Isidoro Pérez Cabeza, Kevin Bowrin, Aleix Llorac Moix, Mar Genís Gironès, David Gasche, Aurélie Millier, Jean Tardu, Mondher Toumi, Jean-Baptiste Briere
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0266658 (2022)
AimsA Markov model was adapted to assess the real-world cost-effectiveness of rivaroxaban, dabigatran and apixaban. Each of these non-vitamin K antagonist oral anticoagulants was compared with vitamin K antagonist for stroke prevention in patients wi
Externí odkaz:
https://doaj.org/article/eb092c35bbd84ed6aa5885bab357e8be
Autor:
Mondher Toumi, Aurélie Millier, Olivier Cristeau, Katia Thokagevistk-Desroziers, Julie Dorey, Samuel Aballéa
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Objectives: While several authors have suggested using a multi-criteria approach for orphan drug assessment and proposed lists of determinants of orphan drug value, studies on social preferences regarding these determinants remain limited. The curren
Externí odkaz:
https://doaj.org/article/d3ad0261ae8847a59e9c0abc3e11e490
Publikováno v:
Journal of Market Access & Health Policy, Vol 8, Iss 1 (2020)
Background Morbidity and mortality associated with non-valvular atrial fibrillation (NVAF) imposes a substantial economic burden on the UK healthcare system. Objectives An existing Markov model was adapted to assess the real-world cost-effectiveness
Externí odkaz:
https://doaj.org/article/5e95112410e74f1183cf795e93f044e3
Autor:
Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Postma, Mondher Toumi
Publikováno v:
Journal of Market Access & Health Policy, Vol 8, Iss 1 (2020)
Objective: To provide recommendations for addressing previously identified key challenges in health economic evaluations of Gene Replacement Therapies (GRTs), including: 1) the assessment of clinical effectiveness; 2) the valuation of health outcomes
Externí odkaz:
https://doaj.org/article/94468d6f449f4f42bffe48594a3cb1c3